Daniel M. Jorgensen
Chief Tech/Sci/R&D Officer at Ocugen OpCo, Inc.
Profile
Daniel M.
Jorgensen currently works at Ocugen OpCo, Inc., as Chief Medical Officer from 2017.
Dr. Jorgensen also formerly worked at Critical Path Institute, as Chief Executive Officer from 2022 to 2024, PolyMedix, Inc., as Chief Medical Officer & SVP-Clinical Development, Centers for Disease Control & Prevention, as Epidemic Intelligence Service Officer, Innovation Pharmaceuticals, Inc., as Chief Medical Officer from 2015 to 2016, SANUWAVE Health, Inc., as Chief Medical Officer, Finch Research & Development LLC, as Chief Medical Officer from 2016 to 2017, and Ocugen, Inc., as Chief Medical Officer from 2017 to 2020.
Dr. Jorgensen received his graduate degree from the University of Washington, undergraduate degree and Masters Business Admin degree from Yale University, and doctorate degree from the University of Wisconsin.
Daniel M. Jorgensen active positions
| Companies | Position | Start |
|---|---|---|
| Ocugen OpCo, Inc. | Chief Tech/Sci/R&D Officer | 2017-03-31 |
Former positions of Daniel M. Jorgensen
| Companies | Position | End |
|---|---|---|
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Chief Executive Officer | 2024-01-08 |
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | 2020-07-14 |
Finch Research & Development LLC
 Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The private company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Chief Tech/Sci/R&D Officer | 2017-03-31 |
| INNOVATION PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 2016-02-29 |
Centers for Disease Control & Prevention
 Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | Corporate Officer/Principal | - |
Training of Daniel M. Jorgensen
| University of Wisconsin | Doctorate Degree |
| Yale University | Masters Business Admin |
| University of Washington | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SANUWAVE HEALTH, INC. | Health Technology |
| INNOVATION PHARMACEUTICALS INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Private companies | 5 |
|---|---|
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
Finch Research & Development LLC
Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The private company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Health Technology |
| Ocugen OpCo, Inc. | |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | Government |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Commercial Services |
- Stock Market
- Insiders
- Daniel M. Jorgensen